公开(公告)号：US20240197927A1

公开(公告)日：2024-06-20

申请号：US18541604

申请日：2023-12-15

Applicant: Fusion Pharmaceuticals Inc.

Inventor： Diane-Charlotte Imbs ,  Elodie Lewkowicz ,  Alexander McEwan ,  Thomas Rohban ,  Sylvie Rolland ,  Daniel Stevens ,  John R. Forbes

IPC: A61K51/04 ,  A61K31/7068 ,  A61K47/64 ,  A61P35/00

CPC classification number: A61K51/0482 ,  A61K31/7068 ,  A61K47/643 ,  A61P35/00

Abstract: The present invention relates to a combination comprising a neurotensin receptor binding compound, gemcitabine and nab-paclitaxel for use for the treatment of a neurotensin receptor overexpressing tumour in a subject.

公开(公告)号：US20240207455A1

公开(公告)日：2024-06-27

申请号：US18541618

申请日：2023-12-15

Applicant: Fusion Pharmaceuticals Inc.

Inventor： Stephan Klinz ,  Diane-Charlotte Imbs ,  Elodie Lewkowicz ,  Sylvie Rolland ,  Thomas Rohban ,  John R. Forbes

IPC: A61K51/04 ,  A61K9/00 ,  A61K31/4745 ,  A61K31/513 ,  A61K31/519 ,  A61K31/555 ,  A61P35/02

CPC classification number: A61K51/0482 ,  A61K9/0019 ,  A61K31/4745 ,  A61K31/513 ,  A61K31/519 ,  A61K31/555 ,  A61P35/02 ,  A61K2121/00

Abstract: The present invention relates to a combination comprising a neurotensin receptor binding compound and NAPOX for use for the treatment of a neurotensin receptor overexpressing tumour in a subject.

公开(公告)号：US20240216550A1

公开(公告)日：2024-07-04

申请号：US18541534

申请日：2023-12-15

Applicant: Fusion Pharmaceuticals Inc.

Inventor： Stephan Klinz ,  Diane-Charlotte Imbs ,  Elodie Lewkowicz ,  Sylvie Rolland ,  Thomas Rohban ,  John R. Forbes

IPC: A61K51/04 ,  A61K9/127 ,  A61K31/4745 ,  A61K31/513 ,  A61K31/519 ,  A61P35/00

CPC classification number: A61K51/0453 ,  A61K9/127 ,  A61K31/4745 ,  A61K31/513 ,  A61K31/519 ,  A61P35/00

Abstract: The present invention relates to a combination comprising a neurotensin receptor binding compound and NAPOLI for use for the treatment of a neurotensin receptor overexpressing tumour in a subject.

公开(公告)号：US20240207276A1

公开(公告)日：2024-06-27

申请号：US18541584

申请日：2023-12-15

Applicant: Fusion Pharmaceuticals Inc.

Inventor： Diane-Charlotte Imbs ,  Elodie Lewkowicz ,  Alexander McEwan ,  Thomas Rohban ,  Sylvie Rolland ,  Daniel Stevens ,  John R. Forbes

IPC: A61K31/519 ,  A61K31/282 ,  A61K31/4745 ,  A61K31/513 ,  A61K51/04 ,  A61P35/00

CPC classification number: A61K31/519 ,  A61K31/282 ,  A61K31/4745 ,  A61K31/513 ,  A61K51/0497 ,  A61P35/00

Abstract: The present invention relates to a combination comprising a neurotensin receptor binding compound and FOLFIRINOX for use for the treatment of a neurotensin receptor overexpressing tumour in a subject.